Edition:
United States

Protalix Biotherapeutics Inc (PLX.TA)

PLX.TA on Tel Aviv Stock Exchange

239.50ILa
16 Nov 2017
Change (% chg)

0.20 (+0.08%)
Prev Close
239.30
Open
237.10
Day's High
245.20
Day's Low
237.10
Volume
118,922
Avg. Vol
458,971
52-wk High
549.00
52-wk Low
110.50

Chart for

About

Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system (ProCellEx). The Company has developed taliglucerase alfa (marketed under the name Uplyso in Brazil and certain other... (more)

Overall

Beta: 0.27
Market Cap(Mil.): ₪324.16
Shares Outstanding(Mil.): 139.73
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 185.06 15.80
EPS (TTM): -- -- --
ROI: -- -10.84 12.07
ROE: -- -39.67 16.02

Earnings vs. Estimates